Skip to main content
. 2024 Apr 26;5(6):851–859. doi: 10.34067/KID.0000000000000452

Table 1.

Baseline characteristics overall and by dipstick proteinuria value

Characteristics, N (%) Overall
N=11,229
Negative/Trace
n=7956
30 mg/dl
n=1700
100 mg/dl
n=1219
≥300 mg/dl
n=354
P Value
Male sex, n/total n (%) 5165/11,227 (46.0) 3549/7954 (44.6)2c 807 (47.5) 629 (51.6) 180 (50.8) <0.001
Age, yr, mean±SD 58.3±17.0 58.0±16.71a,2c 58.9±17.8 59.9±17.46a 57.4±17.4 <0.001
Race, n/total n (%) <0.001a
 White 6017/9756 (61.7) 4346/6804 (63.9) 896/1527 (58.7) 623/1103 (56.5) 152/322 (47.2)
 Black 2502/9756 (25.6) 1500/6804 (22.0) 492/1527 (32.2) 382/1103 (34.6) 128/322 (39.8)
 Asian 844/9756 (8.7) 700/6804 (10.3) 79/1527 (5.2) 49/1103 (4.4) 16/322 (5.0)
 American Indian or Alaska Native 49/9756 (0.5) 35/6804 (0.5) 8/1527 (0.5) 5/1103 (0.5) 1/322 (0.3)
 Native Hawaiian or Other Pacific Islander 16/9756 (0.2) 11/6804 (0.2) 3/1527 (0.2) 2/1103 (0.2) 0/322 (0.0)
 Other 328/9756 (3.4) 212/6804 (3.1) 49/1527 (3.2) 42/1103 (3.8) 25/322 (7.8)
Diabetes mellitus, n (%) 3090 (27.5) 1828 (23.0)1c,2c,3c 591 (34.8)4b,5c 494 (40.5)6b 177 (50.0) <0.001
Hypertension, n (%) 5756 (51.3) 3640 (45.8)1c,2c,3c 1046 (61.5)4b,5b 818 (67.1) 252 (71.2) <0.001
CAD, n/total n (%) 1331/6203 (21.5) 803/3932 (20.4) 262/1137 (23.0) 212/867 (24.5) 54/267 (20.2) 0.04
ACEi/ARB, n/total n (%) 3370/6203 (54.3) 2124/3932 (54.0) 624/1137 (54.9) 493/867 (56.9) 129/267 (48.3) 0.9
SG, median (IQR) 1.016 (1.011–1.021) 1.015 (1.011–1.020)1c,2c,3b 1.019 (1.014–1.025)4c,5c 1.016 (1.012–1.021) 1.016 (1.013, 1.020) <0.001
eGFR, mean±SD, ml/min per 1.73 m2 71.81±31.48 77.49±28.061c,2c,3c 67.24±33.504c,5c 51.51±33.576c 39.06±32.46 <0.001
eGFR ≥60 ml/min per 1.73 m2, n/total n (%) 6122/9722 (63.0) 4896/6868 (71.3)1c,2c,3c 808/1463 (55.2)4c,5c 352/1065 (33.1)6c 66/326 (20.2) <0.001
eGFR cutoffs, ml/min per 1.73 m 2 , n/total n (%) <0.001b
 ≥90 3161/9722 (32.5) 2518/6868 (36.7) 439/1463 (30.0) 168/1065 (15.8) 36/326 (11.0)
 60–89 2961/9722 (30.5) 2378/6868 (34.6) 369/1463 (25.2) 184/1065 (17.3) 30/326 (9.2)
 45–59 1389/9722 (14.3) 985/6868 (14.3) 202/1463 (13.8) 170/1065 (16.0) 32/326 (9.8)
 30–44 1131/9722 (11.6) 642/6868 (9.3) 219/1463 (15.0) 209/1065 (19.6) 61/326 (18.7)
 15–29 746/9722 (7.7) 299/6868 (4.4) 159/1463 (10.9) 200/1065 (18.8) 88/326 (27.0)
 <15 334/9722 (3.4) 46/6868 (0.7) 75/1463 (5.1) 134/1065 (12.6) 79/326 (24.2)

To compare across dipstick proteinuria categories, we used the Cochran–Armitage trend test for binary categorical variables, generalized Pearson chi-square test for the nominal categorical variable with more than two levels and linear-by-linear association test for ordinal categorical variable with more than two levels. We applied the Jonckheere–Terpstra test for continuous variables. Pairwise comparisons among negative or trace, 30, 100, and ≥300 mg/dl were performed when the overall test was significant, and the adjustment to P values was based on the Holm method. Pairwise for race value and GFR cutoffs are for overall differences. ACEi/ARB, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers; CAD, coronary artery disease; IQR, interquartile range; SG, specific gravity; UACR, urine albumin-to-creatinine ratio; UPCR, urine protein-to-creatinine ratio.

Pairwise comparison between negative/trace and 30 mg/dl: 1aP < 0.05, 1bP < 0.01, 1cP < 0.001.

Pairwise comparison between negative/trace and 100 mg/dl: 2aP < 0.05, 2bP < 0.01, 2cP < 0.001.

Pairwise comparison between negative/trace and ≥300 mg/dl: 3aP < 0.05, 3bP < 0.01, 3cP < 0.001.

Pairwise comparison between 30 and 100 mg/dl: 4aP < 0.05, 4bP < 0.01, 4cP < 0.001.

Pairwise comparison between 30 and ≥300 mg/dl: 5aP < 0.05, 5bP < 0.01, 5cP < 0.001.

Pairwise comparison between 100 and ≥300 mg/dl: 6aP < 0.05, 6bP < 0.01, 6cP < 0.001.

a

Pairwise comparison for overall race variable: 1c, 2c, 3c, 5c, 6a.

b

Pairwise comparison for overall eGFR cutoffs: 1c, 2c, 3c, 4c, 5c, 6c